What does CUSIP 61023L108 represent in this 13F holders report?

CUSIP 61023L108 is the security identifier for MNPR - MONOPAR THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held MNPR - MONOPAR THERAPEUTICS INC - COM in Q4 2023?

14 institutional investors reported MNPR - MONOPAR THERAPEUTICS INC - COM for Q4 2023. Use the holders table for investor-level position and value details.

MONOPAR THERAPEUTICS INC - COM (MNPR)

CUSIP: 61023L108

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / COM
Total 13F shares: 271,392
Total 13F value: $91,706
Share change: -58,003
SEC-reported price per share: $0.34
Number of holders: 14
Value change: -$54,955
Number of buys: 7
Number of sells: 6

Security key

61023L108

Report period

Q4 2023

Institutions

Top holders

MNPR full security history Ownership snapshot Full 13F holder table Monopar Therapeutics SEC filings Monopar Therapeutics company facts Monopar Therapeutics 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MNPR - MONOPAR THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Michael J. Brown

Disclosed value leader

Michael J. Brown

Comparable rows

0/15

Latest evidence

31 Dec 2023

3/4/5 13F Highest disclosed value: $136,941 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Michael J. Brown has the largest disclosed position value at $136.9K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Michael J. Brown's linked filing trail.

Disclosed position value Top 5

Michael J. Brown $136.9K

Andrew Paul Mazar $94.4K

Windsor Advisory Group, LLC $55.8K

VANGUARD GROUP INC $54.3K

GEODE CAPITAL MANAGEMENT, LLC $23.5K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Michael J. Brown	3/4/5 Director 3/4/5	— denominator unverified	$136,941 402,530 shares	—	31 Dec 2023
Andrew Paul Mazar	3/4/5 Chief Scientific Officer, Director 3/4/5	— mixed-class rows	$94,434 277,584 shares mixed-class rows	—	31 Mar 2022
Windsor Advisory Group, LLC	13F Company 13F	— denominator unverified	$55,775 89,974 shares	—	30 Sep 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$54,301 87,596 shares	—	30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$23,483 41,199 shares	—	30 Sep 2023
TWO SIGMA SECURITIES, LLC	13F Company 13F	— denominator unverified	$15,289 24,663 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

271,392

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %